Ghe LLC grew its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 1.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,938 shares of the company’s stock after purchasing an additional 338 shares during the period. Colgate-Palmolive makes up about 0.9% of Ghe LLC’s holdings, making the stock its 24th largest holding. Ghe LLC’s holdings in Colgate-Palmolive were worth $2,138,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in CL. Pinnacle Financial Partners Inc grew its position in Colgate-Palmolive by 1.1% in the third quarter. Pinnacle Financial Partners Inc now owns 25,117 shares of the company’s stock worth $2,607,000 after acquiring an additional 279 shares during the period. MQS Management LLC purchased a new position in Colgate-Palmolive in the third quarter worth approximately $1,054,000. Empower Advisory Group LLC grew its position in Colgate-Palmolive by 4.9% in the third quarter. Empower Advisory Group LLC now owns 173,798 shares of the company’s stock worth $18,042,000 after acquiring an additional 8,047 shares during the period. Carrera Capital Advisors grew its position in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the period. Finally, Victory Capital Management Inc. grew its position in Colgate-Palmolive by 17.4% in the third quarter. Victory Capital Management Inc. now owns 2,475,066 shares of the company’s stock worth $256,937,000 after acquiring an additional 366,708 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Price Performance
Shares of CL stock traded up $0.09 during midday trading on Wednesday, reaching $91.59. 210,756 shares of the company traded hands, compared to its average volume of 4,357,673. The firm’s 50 day simple moving average is $100.30 and its two-hundred day simple moving average is $98.53. Colgate-Palmolive has a 1-year low of $75.17 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market cap of $74.83 billion, a PE ratio of 26.22, a price-to-earnings-growth ratio of 3.28 and a beta of 0.42.
Colgate-Palmolive Dividend Announcement
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.
Analysts Set New Price Targets
CL has been the subject of several research analyst reports. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Barclays increased their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research note on Monday, July 29th. Sanford C. Bernstein increased their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research note on Tuesday, July 30th. Piper Sandler started coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price objective on the stock. Finally, JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.
View Our Latest Research Report on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Learn Technical Analysis Skills to Master the Stock Market
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Conference Calls and Individual Investors
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Is Palantir’s AI Edge Enough to Justify Its Price?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.